Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes.
about
Preclinical carotid atherosclerosis in patients with latent autoimmune diabetes in adults (LADA), type 2 diabetes and classical type 1 diabetes.A review on cardiovascular effects of newer hypoglycaemic medications.SIRT1 Activation by Resveratrol Alleviates Cardiac Dysfunction via Mitochondrial Regulation in Diabetic Cardiomyopathy Mice.Relationship between hemoglobin glycation index and extent of coronary heart disease in individuals with type 2 diabetes mellitus: a cross-sectional study.Mortality in adults with and without diabetes: is the gap widening?Antidiabetic medications and mortality reduction: a shift from surrogate to clinical endpoints.Life expectancy with and without cognitive impairment by diabetes status among older Americans.Pharmacological management of type 2 diabetes: what's new in 2017?Cardiovascular Outcomes Trials in Type 2 Diabetes: Where Do We Go From Here? Reflections From a Diabetes Care Editors' Expert Forum.Eating behaviors and emotional distress are predicted by treatment and adverse outcome in patients with type 2 diabetes.The future of nuclear cardiac imaging: Reflection and a vision.Sodium-glucose co-transporter-2 inhibitors and cardiovascular outcome studies in people with type 2 diabetes: From efficacy to effectiveness.Body mass index as a risk factor for coronary events and mortality in patients with type 1 diabetes.Fighting residual cardiovascular risk in stable patients with atherosclerotic vascular disease: COMPASS in context.Reduced Long-Term Risk of Aortic Aneurysm and Aortic Dissection Among Individuals With Type 2 Diabetes Mellitus: A Nationwide Observational Study.Work-loss years among people diagnosed with diabetes: a reappraisal from a life course perspective.Coronary Disease Survival with Diabetes.Diabetes: Cardiovascular benefits of metformin in T1DM.Estimated glucose disposal rate predicts mortality in adults with type 1 diabetes.Macrovascular disease and risk factors in youth with type 1 diabetes: time to be more attentive to treatment?Association between refill adherence to lipid-lowering medications and the risk of cardiovascular disease and mortality in Swedish patients with type 2 diabetes mellitus: a nationwide cohort study.Psychological interventions for behavioral adjustments in diabetes care - a value-based approach to disease control.Cardiovascular Effects of New Oral Glucose-Lowering Agents: DPP-4 and SGLT-2 Inhibitors.Progression of diabetes, heart disease, and stroke multimorbidity in middle-aged women: A 20-year cohort study.Nonfasting Apo-lipoprotein B and Triglyceride levels as a predictor of coronary heart disease in Type II diabetic patients.Pioglitazone and cardiovascular risk in T2DM patients: is it good for all?Skin autofluorescence predicts major adverse cardiovascular events in patients with type 1 diabetes: a 7-year follow-up study.Periconception glycaemic control in women with type 1 diabetes and risk of major birth defects: population based cohort study in Sweden.Association Between Use of Sodium-Glucose Cotransporter 2 Inhibitors, Glucagon-like Peptide 1 Agonists, and Dipeptidyl Peptidase 4 Inhibitors With All-Cause Mortality in Patients With Type 2 Diabetes: A Systematic Review and Meta-analysisEffectiveness of Coenzyme Q10 Supplementation for Type 2 Diabetes Mellitus: A Systematic Review and Meta-AnalysisAspects of Multicomponent Integrated Care Promote Sustained Improvement in Surrogate Clinical Outcomes: A Systematic Review and Meta-analysisTrends of Diabetes Epidemic in KoreaExcess risk of hospitalisation for heart failure among people with type 2 diabetes
P2860
Q38657107-F232F20C-8F4C-4A0A-A687-D951879EFD12Q39328296-81121877-B4FE-4B57-A947-3A1405594964Q41528591-867A64F0-703B-4B4C-8354-892BD20E3D4AQ42270747-8D0F6260-D66C-445C-861B-73C6A0A2E6AFQ44113960-54FE9654-7D07-455F-94D7-4037EC74B1D2Q47132021-957D480B-887D-43F7-BA87-D75FE8D954B6Q47233990-C07B8559-F0E3-4084-9B0E-6722F7D89841Q47696671-75755574-DF02-4B5D-A3D3-EFDDF22562B4Q47771118-B69622E2-569C-42A4-8F9A-E1D912AB9ED3Q47777898-977801B1-652F-4EE8-BBD5-9740BE7D528BQ47891438-48B158F8-EECC-4F04-B4D1-60E378C41A42Q48114481-9F48D21F-E432-40E1-A7CA-CEF4CB7BDEB5Q48129352-613A803C-991D-4E96-BBA3-8F27FD68F846Q49549481-2E5EACF1-F7B4-4541-80FB-1DA3DA5908DAQ49788540-89C91FCB-133F-4CF8-8889-75F1FBD89425Q49891039-DECCFF8F-B21F-4929-9718-81EC20E4CC30Q49972168-8FC0B0EB-9CA2-4158-8D2C-ED2664968DACQ50140150-A9CCA9EC-5B24-4BAF-BDCD-0E329A38FA04Q50200240-44CFB825-E07B-4944-90E7-B49E8DA1CE97Q52687795-0224B8AB-937C-47C7-97D9-3621B2E17C3BQ53833642-9443E482-E591-4F83-B2AF-B5212CFE19B5Q55001893-5EFDD10A-3B7B-49B0-8D5C-0E81F405C4BBQ55053753-1BB7B5A9-F12E-49A2-AC58-782C4DF50627Q55282400-C516B2E6-DC61-4E3B-BF9A-CF2290BFFDA5Q55315345-18D9DDD9-8DF8-4E49-B4C8-0DB9D73408E0Q55397745-B0FD29FF-ED46-44DD-8364-37E70210B8F4Q55450240-0A9C5646-2492-4BDB-B7E9-42B876AD65F8Q55471235-AA98C48A-90EE-44C8-A80C-35C98A42840CQ55879040-9E05F106-8533-4F7C-826A-3D0CF6498556Q57300294-AD4DAB1A-2338-4F3B-BAA5-78E11FA966CCQ58209266-597A896B-8A3E-41AF-8082-70A4C4F6DEA0Q58591183-DEBBE8B0-171C-450E-A8B5-99F7EE85EF1CQ58791854-2DA4FED6-2BCB-44E3-8056-1C62A636D815
P2860
Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes.
@en
type
label
Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes.
@en
prefLabel
Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes.
@en
P2093
P50
P921
P356
P1476
Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes.
@en
P2093
Aidin Rawshani
Ann-Marie Svensson
Araz Rawshani
Björn Eliasson
Darren K McGuire
Stefan Franzén
P304
P356
10.1056/NEJMOA1608664
P407
P577
2017-04-01T00:00:00Z